Featured
Developments for Parkinson’s Disease Ignite Investor Enthusiasm
In our August 2009 article titled “Treating Parkinson’s Disease: Investment Opportunities and Challenges,” we reviewed some of the historical challenges associated with developing treatments for Parkinson’s disease [PD] and cited reasons for optimism going forward in addition to highlighting several promising companies making progress. Since... Read more of this article
More Posts From Featured
Articles
Ache-free Investment Opportunities in Neuropathic Pain
In the United States, up to 50 million people live with chronic pain, with the majority...
Bayer’s Bold New Bet Fails to Rain on Spectrum Pharmaceuticals
Despite recent progress and the availability of novel therapies, radiation is still...
Three Recent Biotechnology Activist Wins by Carl Icahn
Although a controversial topic, activist hedge funds and private equity firms typically...
Cash for Cardiovascular: Who Might be Next?
In January 2007, Amgen, Inc. (AMGN) obtained an option from Cytokinetics, Inc. (CYTK)...
More Posts From Articles
Opinion Editorials (OpEd)
Innovative New Medicines are Key to Economic Growth
The life sciences industry [herein includes pharmaceutical, biotechnology, diagnostic...
Bridging the Gap – Translating NIH Funding in a Post-Stimulus Economy
On February 17, 2009, President Obama announced as part of the 2009 stimulus bill,...
Bailout for Banks and Auto Industry…What about Biotechnology?
As the CEO of a few small, publicly-traded biotechnology companies during the past...
More Posts From Opinion Editorials (OpEd)
